SCHEMBL23879258

SCHEMBL23879258

NC(=O)C(c1ccc(Cl)nn1)c1cc(Cl)ccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ALDH1A1 P00352 5/20 0.45
GAA P10253 2/20 0.45
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
KCNH2 Q12809 2/20 0.36
TP53 P04637 1/20 0.33
EPHX1 P07099 1/20 0.32
POLB P06746 1/20 0.32
MEN1 O00255 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
SLC9A1 P19634 1/20 0.32
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452602 1.00 HTT (0.45) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL23879241 0.89 ALDH1A1 (0.55) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL30452623 0.85 TSHR (0.41) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL23879240 0.85 TSHR (0.41) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL30452681 0.81 PLAU (0.37) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL23879233 0.81 PLAU (0.37) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL30453636 0.78 HTT (0.49) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL23879278 0.78 HTT (0.49) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL23879246 0.78 HTT (0.51) HTTMAPTSMN1; SMN2NPSR1ALDH1A1
SCHEMBL23879281 0.77 ALDH1A1 (0.43) HTTMAPTSMN1; SMN2NPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111253404-B Nitrogen-containing heterocyclic compound and composition, preparation method and application thereof 上海医药集团股份有限公司 2023-05-23 CN disclosed
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) 2022-02-17 US disclosed
EP-3889156-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Shanghai Pharmaceuticals Holding Co., Ltd. (CN) 2021-10-06 EP disclosed
CN-111253404-A Nitrogen-containing heterocyclic compound and composition, preparation method and application thereof 上海医药集团股份有限公司 2020-06-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048915-A1 Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof MAPK11, WEE1, NOS1 HTT 4033/4885MAPT 4194/4885SMN1; SMN2 3987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.